Hong Kong GI underwriting profits plunged 42% in 2021: HKIA
October 3 2022 by Mithun Varkey
-
Singapore’s MS First Capital Insurance’s rating outlook upgraded to positive
- November 15
The global rating agency revises MSFC’s outlooks to positive, affirms financial strength rating of A (excellent) and long-term issuer credit rating of “a+” (excellent).
-
The Hartford makes Singapore foray with Axa XL hire
- November 7
Zhenghong Pan will join the specialty carrier in Singapore as principal officer & underwriting manager, financial lines.
-
Axa XL plans Asia ‘acceleration’ as it looks to double portfolio by 2026
- November 7
The carrier eyes significant growth opportunities across India, China, Thailand and Indonesia as it plans to cement its position as a leading regional player.
-
Arch Indemnity could see underwriting results moderate as claims set to pick up: Fitch
- November 4
The rating agency has assigned an 'A+' (strong) rating with a stable outlook to the carrier due to its moderate company profile, very strong capitalisation, financial performance and earnings, and support from the parent Arch Capital Group.
-
BHSI | Managing non-Asian exposure in long-tail lines
While US-exposed business can look attractive to Asian carriers, managing the volatility around the long-term results and the ability to model those losses are crucial, say BHSI’s Marc Breuil and Marcus Portbury.
-
Sedgwick | To Handle CAT Claims Well, Multi-Step Preparation is Key
When it comes to risk, it’s not a matter of “if” it’s a matter of “when” an event will occur.
-
HSBC Asset Management | Is it time to relook at Asian currency bonds?
With diversification and performance high on investors’ agendas, it seems a good time for global portfolios to revive allocations in Asian local currency bonds – including Hong Kong dollar (HKD) bonds.
-
PineBridge Investments | Why Asian insurers are exploring private credit and CLOs
The recent rollout of risk-based capital regimes across Asia calls for a closer alignment between insurers’ assets and liabilities. We explore potential ways to maintain a healthy investment yield and robust returns on regulatory capital.
